Related Experiment Video

Updated: Feb 2, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.2K

Heart Failure in Women with Congenital Heart Disease

Elisa A Bradley1, Anita Saraf2, Wendy Book2

  • 1Department of Internal Medicine, Division of Cardiovascular Medicine, Dorothy Davis Heart and Lung Research Institute, The Ohio State University, 473 W 12th Avenue Suite 200, Columbus, OH 43210, USA.

Heart Failure Clinics
|November 20, 2018
PubMed

Insights

Adults with congenital heart disease (CHD) face significant risks of heart failure (HF). Women with CHD appear more susceptible to late-onset HF, requiring specialized care throughout their lives.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease (ACHD)

Background:

  • Heart failure (HF) is a primary cause of death and illness in adults with congenital heart disease (CHD).
  • Emerging evidence suggests women with CHD may experience higher rates of late-onset HF compared to men.

Purpose of the Study:

  • To highlight the increased risk of heart failure in women with adult congenital heart disease.
  • To emphasize the need for specialized care for aging women with CHD.

Main Methods:

  • Review of existing literature on heart failure in adult congenital heart disease.
  • Analysis of gender-specific outcomes in adult congenital heart disease populations.

Main Results:

  • Heart failure is the leading cause of morbidity and mortality in adults with CHD.
  • Women with CHD may be disproportionately affected by late-onset heart failure.

Conclusions:

  • Specialized adult CHD teams are essential for managing aging women with CHD.
  • Care should include assessing reversible causes of HF and managing pregnancy-related cardiovascular risks.

Keywords:
Adult congenital heart diseaseHeart failurePregnancyWomen

More Related Videos

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K
Gene Transfer for Ischemic Heart Failure in a Preclinical Model07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

13.4K

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319